Immersive Virtual Reality (VR) at the Time of Clinical Evaluation to Improve Psychological Distress and Anxiety in Primary Brain Tumor (PBT) Patients

NCT04301089 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

61

Enrollment

NIH

Sponsor class

Conditions

Anxiety

Interventions

DEVICE: Pico G2 4K Headset with Applied VR software
OTHER: Patient Reported Questionnaires
BIOLOGICAL: Saliva sample collection (hormones)

Sponsor

National Cancer Institute (NCI)